Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
US-12503733-B2 · Dec 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ebert Benjamin Levine patents
Ebert Benjamin Levine is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ebert Benjamin Levine |
| Total patents | 20 |
| First publication | Jun 16, 2016 |
| Latest publication | Dec 23, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
US-2024167093-A1 · May 23, 2024 · US
Disease biomarkers and treatment methods related thereto
US-11785925-B2 · Oct 17, 2023 · US
Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
US-11788144-B2 · Oct 17, 2023 · US
Methods of characterizing resistance to modulators of Cereblon
US-11459613-B2 · Oct 4, 2022 · US
Methods of characterizing resistance to modulators of cereblon
US-2022251651-A1 · Aug 11, 2022 · US
Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
US-2022170100-A1 · Jun 2, 2022 · US
Methods of identifying drug-modulated polypeptide targets for degradation
US-2022017938-A1 · Jan 20, 2022 · US
Methods of identifying a polypeptide target for degradation by a modulator of CRBN
US-11168345-B2 · Nov 9, 2021 · US
Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects
US-10711308-B2 · Jul 14, 2020 · US
Recent patents
Latest publications not already listed above.
Knock-in rodent comprising a mutation in an endogenous crbn locus and methods of use thereof
US-2019274292-A1 · Sep 12, 2019 · US
IMiD screening methods IMiD-sensitive cells with mutant CRBN
US-10334829-B2 · Jul 2, 2019 · US
Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and Compositions
US-2019106710-A1 · Apr 11, 2019 · US
Methods of identifying drug-modulated polypeptide targets for degradation
US-2019071731-A1 · Mar 7, 2019 · US
Knock-in rodent comprising a mutation in an endogenous crbn locus and methods of use thereof
US-2018343839-A1 · Dec 6, 2018 · US
Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof
US-9974289-B2 · May 22, 2018 · US
Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
US-2018010185-A1 · Jan 11, 2018 · US
Knock-in rodent comprising a mutation in an endogenous crbn locus and methods of use thereof
US-2016338326-A1 · Nov 24, 2016 · US
Compositions and methods for selecting a treatment for b-cell neoplasias
US-2016282354-A1 · Sep 29, 2016 · US
Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions
US-2016168594-A1 · Jun 16, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Brigham & Womens Hospital Inc | 19 |
| Broad Inst Inc | 12 |
| Massachusetts Gen Hospital | 4 |
| Ebert Benjamin Levine | 4 |
| Harvard College | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12Q2600/156 | 18 |
| C12Q1/6886 | 16 |
| C12Q2600/158 | 12 |
| C12Q2600/106 | 12 |
| C12Q1/6883 | 11 |